Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 1 Diabetes
- People aged 6 years or older, of any gender
- People whose Type 1 Diabetes diagnosis was more than 3 months ago
- People who are planning to attend follow-up appointments at the study hospital over the next year
- People who have enough cognitive ability to operate the devices used in the study
- People who are willing to use a continuous glucose monitor and an insulin pump, upload their data, and take part in remote monitoring
- People who are willing to attend structured education sessions and camp activities on time (this applies to the intervention group only)
- People who are willing and able to follow the study protocol
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who are planning to receive their diabetes care at a different hospital during the study
- People who have used an automated insulin delivery system or a sensor-assisted insulin pump in the 3 months before the screening visit
- People who are not willing to use a continuous glucose monitor or insulin pump, or who do not want their data uploaded or remotely monitored
- People who have serious heart, stroke-related, liver, or kidney conditions; uncontrolled ongoing illnesses; thyroid conditions; autoimmune conditions; or cancer
- People who have a blood disorder or a condition that affects bleeding
- People who have received a red blood cell transfusion or medication to stimulate red blood cell production in the 3 months before the screening visit
- People who have used steroid medications (taken by mouth, injection, or drip) in the 8 weeks before the screening visit, or who plan to use steroids during the trial
- People with serious skin conditions in the areas where the glucose monitor or insulin pump patch would be applied
- People with hearing or vision impairments
- People with a history of alcohol or drug misuse
- People who are planning to receive a blood transfusion during the study
- People who are planning to have a non-urgent surgery under general anaesthesia, or to undergo dialysis, during the study
- Women who are pregnant, breastfeeding, or planning to become pregnant within 1 year of the study
- People who are currently taking part in, or have taken part in, another medicine or device trial within the last 2 weeks
- People who the study investigator considers unsuitable for the trial for other reasons, such as a history of vision impairment, eating disorders, or coeliac disease (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xia Li, MD, PhD, Second Xiangya Hospital of Central South University
Phone: +86 13974885753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.